Mesoblast Management
Management criteria checks 3/4
Mesoblast's CEO is Silviu Itescu, appointed in Jan 2011, has a tenure of 13.17 years. total yearly compensation is $1.11M, comprised of 60.6% salary and 39.4% bonuses, including company stock and options. directly owns 6.94% of the company’s shares, worth A$39.19M. The average tenure of the management team and the board of directors is 4.4 years and 5.8 years respectively.
Key information
Silviu Itescu
Chief executive officer
US$1.1m
Total compensation
CEO salary percentage | 60.6% |
CEO tenure | 13.2yrs |
CEO ownership | 6.9% |
Management average tenure | 4.4yrs |
Board average tenure | 5.8yrs |
Recent management updates
Recent updates
Does Mesoblast (ASX:MSB) Have A Healthy Balance Sheet?
Jun 21Does Mesoblast (ASX:MSB) Have A Healthy Balance Sheet?
Jun 06Auditors Are Concerned About Mesoblast (ASX:MSB)
Sep 04Analysts Are More Bearish On Mesoblast Limited (ASX:MSB) Than They Used To Be
Mar 04Should Mesoblast (ASX:MSB) Be Disappointed With Their 54% Profit?
Feb 23CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | -US$73m |
Sep 30 2023 | n/a | n/a | -US$81m |
Jun 30 2023 | US$1m | US$673k | -US$82m |
Mar 31 2023 | n/a | n/a | -US$81m |
Dec 31 2022 | n/a | n/a | -US$84m |
Sep 30 2022 | n/a | n/a | -US$86m |
Jun 30 2022 | US$1m | US$697k | -US$91m |
Mar 31 2022 | n/a | n/a | -US$92m |
Dec 31 2021 | n/a | n/a | -US$97m |
Sep 30 2021 | n/a | n/a | -US$97m |
Jun 30 2021 | US$2m | US$757k | -US$99m |
Mar 31 2021 | n/a | n/a | -US$109m |
Dec 31 2020 | n/a | n/a | -US$98m |
Sep 30 2020 | n/a | n/a | -US$97m |
Jun 30 2020 | US$2m | US$697k | -US$78m |
Mar 31 2020 | n/a | n/a | -US$66m |
Dec 31 2019 | n/a | n/a | -US$76m |
Sep 30 2019 | n/a | n/a | -US$76m |
Jun 30 2019 | US$1m | US$709k | -US$90m |
Mar 31 2019 | n/a | n/a | -US$90m |
Dec 31 2018 | n/a | n/a | -US$86m |
Sep 30 2018 | n/a | n/a | -US$48m |
Jun 30 2018 | US$2m | US$748k | -US$35m |
Mar 31 2018 | n/a | n/a | -US$42m |
Dec 31 2017 | n/a | n/a | -US$30m |
Sep 30 2017 | n/a | n/a | -US$64m |
Jun 30 2017 | US$1m | US$776k | -US$77m |
Compensation vs Market: Silviu's total compensation ($USD1.11M) is above average for companies of similar size in the Australian market ($USD778.29K).
Compensation vs Earnings: Silviu's compensation has been consistent with company performance over the past year.
CEO
Silviu Itescu (66 yo)
13.2yrs
Tenure
US$1,109,634
Compensation
Prof. Silviu Itescu, MBBS (Hons), FRACP, FACP, FACRA, FTSE has been the Chief Executive Officer and Managing Director of Mesoblast Limited since 2011. Prof. Itescu is the Chief Executive Officer at Mesobla...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 13.2yrs | US$1.11m | 6.94% $ 39.2m | |
Chief Medical Officer & Executive Director | 2.1yrs | US$1.02m | no data | |
Interim Chief Finance Officer | 2.6yrs | no data | no data | |
General Counsel & Corporate Executive | 12.7yrs | no data | no data | |
Head of Spinal Orthopedic Disorders | 8.4yrs | no data | no data | |
Head of Pharma Partnering | no data | no data | no data | |
Head of Regulatory Affairs & Quality Management | no data | no data | no data | |
Head of Manufacturing | no data | no data | no data | |
Joint Company Secretary | 4.4yrs | no data | no data | |
Joint Company Secretary | 1.9yrs | no data | no data | |
Executive | no data | no data | no data |
4.4yrs
Average Tenure
66yo
Average Age
Experienced Management: MSB's management team is considered experienced (4.4 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 16.8yrs | US$1.11m | 6.94% $ 39.2m | |
Chief Medical Officer & Executive Director | 10.9yrs | US$1.02m | no data | |
Independent Non-Executive Director | 3yrs | US$135.62k | 0.011% $ 61.2k | |
Independent Non-Executive Chairman | 5.8yrs | US$247.95k | 0.040% $ 228.0k | |
Independent Non-Executive Vice Chairman | 10yrs | US$132.70k | 0.0093% $ 52.7k | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Non-Executive Director | 1.6yrs | US$139.29k | 0.027% $ 153.6k | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Non Executive Director | 2yrs | US$138.33k | 0.034% $ 192.3k |
5.8yrs
Average Tenure
71yo
Average Age
Experienced Board: MSB's board of directors are considered experienced (5.8 years average tenure).